Arkolith/Insider Trading/ELTX/Form 4/A

Venkatesan Jay

DirectorElicio Therapeutics, Inc. (ELTX) · full profile →Form 4/A · filed Jan 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 28, 2024Buy(P)50K$4.99$250K50K
Jun 28, 2024Buy(P)50K—$050K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001601485-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML